BREAKING NEWS:Health officers fast-track regional stay-at-home order

Town Square

Post a New Topic

Remdesivir treatment shows 62% reduction in COVID-19 deaths

Original post made on Jul 14, 2020

The experimental antiviral drug remdesivir reduced the mortality rate in severely ill COVID-19 patients by 62%, Foster City-based manufacturer Gilead Sciences announced Friday.

Read the full story here Web Link posted Tuesday, July 14, 2020, 4:58 PM

Comments (2)

11 people like this
Posted by resident
a resident of Community Center
on Jul 14, 2020 at 5:26 pm

The remdesivir effectiveness news is great, but the USA has so many serious cases of COVID now that hospitals are running out of the drug. Deciding who gets the available supply is a big ethics problem.


2 people like this
Posted by JT
a resident of Another Palo Alto neighborhood
on Jul 15, 2020 at 11:15 am

It would be awesome if you also reported on the great outcomes of HCQ. It has helped many patients as well, instead of reporting on "the anti-malarial drug touted by President Donald Trump" There are many articles out there, you just have to research but that should come easy in your journalism profession.


Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.

Email:


Post a comment

Sorry, but further commenting on this topic has been closed.

Get the most important local news stories sent straight to your inbox daily.

MoDo Hawaii's wildly popular mochi donuts are coming to the Bay Area
By Elena Kadvany | 1 comment | 4,417 views

Couples and Premarital: Personal Weather Report (TM)
By Chandrama Anderson | 0 comments | 2,649 views

Time to tighten up the PA city council meetings
By Diana Diamond | 7 comments | 1,498 views

Our First Year with an Elf on the Shelf
By Cheryl Bac | 2 comments | 1,100 views

 

Honoring local businesses

Local businesses are the heart and soul of our communities. This year, our Best Of special publication honors the beloved institutions that have fought to stay open and support the community. Learn how businesses are pivoting to survive the pandemic and how our 2019 Best Of winners are doing a year later.

READ MORE